Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
2
×
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
amgen
andrew oxtoby
babies
biotech
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
ceo
cholesterol
clinical hold
clinical study
clinical trials
combination
commissioner
congress
crispr
crispr-cas9
data
delisting
democrats
departure
detroit blog main
detroit top stories
drug pricing
editas medicine
eli lilly
What
big
2
×
ceo
2
×
medicine
week
aces
announced
bio
bosley's
bosley’s
bridge
bucks
cas
cholesterol
crime
crispr
departure
drug
editas
exit
flexible
guiding
inclisiran
katrine
key
lowering
meant
medco
medicines
moves
nasdaq
open
passed
personnel
pricing
roundup
surprising
taken
test
twice
year
Language
unset
Current search:
ceo
×
big
×
" san francisco top stories "
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More